Equity Profile

DGX

Quest Diagnostics Incorporated

Health CareHealth Care Services$23.0B

Jul21Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing services in the health care sector. The company plays a crucial role in patient care by offering a wide range of lab tests that help diagnose diseases and monitor health conditions.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its services and capture market share, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DGX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.79%

Avg Stock Reaction

+3.85%

Last Quarter Recap

In Q1-2026, Quest Diagnostics reported an EPS of $2.50, exceeding estimates by 5.44%. The stock reacted positively, gaining 4.45% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, investors are cautiously optimistic about Quest Diagnostics' upcoming earnings report, especially given its strong track record of beating EPS estimates.

Bull Case

If the company continues its trend of exceeding EPS expectations, it could signal robust demand for its services and lead to a significant stock price increase.

Bear Case

On the other hand, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a negative reaction from investors.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's strong history of beating EPS estimates, the actual EPS will be crucial in determining market sentiment.

How is revenue growth trending compared to previous quarters?

Investors will be closely watching revenue growth to assess the company's ability to maintain or accelerate its growth trajectory.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Quest Diagnostics to exceed EPS expectations due to strong demand for diagnostic testing.

Supporting Evidence

Quest has consistently beaten EPS estimates in the past, indicating a strong operational performance.

The options market is pricing a smaller move than historical averages, suggesting that sentiment may be overly cautious.

Key Risk

If the EPS comes in below $2.40, it could undermine the positive sentiment surrounding the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Quest Diagnostics can sustain its growth and profitability in a competitive health care market.

Bull Confirmed If

An EPS of $2.60 or higher would confirm the bull case and suggest strong demand for diagnostic services.

Bear Confirmed If

An EPS below $2.40 would raise concerns about the company's growth prospects and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±2.31%

Historical Avg

±5.7%

Pricing cheap

The options market is pricing in a modest move of about 2.31%, indicating that investors are anticipating a relatively stable reaction to the earnings report.

Options are pricing ±2.3% while DGX has averaged ±5.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

24.2%

Calls (31K)P/C Ratio: 0.25Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Quest Diagnostics beats expectations, history suggests the stock could rise by an average of 3.85%, confirming strong demand for its services.

In-Line / Cautious

If the results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

If the company misses expectations, history suggests a potential decline of around 3.85%, indicating investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new diagnostic tests or services being launched.
2Management's commentary on trends in patient volume and demand for testing.
3Insights into cost management and operational efficiency improvements.
4Discussion on competitive pressures and market share dynamics.
5Guidance on future revenue growth and strategic initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

ICICI Bank Limited

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its services and capture market share, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DGX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.79%

Avg Stock Reaction

+3.85%

Last Quarter Recap

In Q1-2026, Quest Diagnostics reported an EPS of $2.50, exceeding estimates by 5.44%. The stock reacted positively, gaining 4.45% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, investors are cautiously optimistic about Quest Diagnostics' upcoming earnings report, especially given its strong track record of beating EPS estimates.

Bull Case

If the company continues its trend of exceeding EPS expectations, it could signal robust demand for its services and lead to a significant stock price increase.

Bear Case

On the other hand, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a negative reaction from investors.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's strong history of beating EPS estimates, the actual EPS will be crucial in determining market sentiment.

How is revenue growth trending compared to previous quarters?

Investors will be closely watching revenue growth to assess the company's ability to maintain or accelerate its growth trajectory.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Quest Diagnostics to exceed EPS expectations due to strong demand for diagnostic testing.

Supporting Evidence

Quest has consistently beaten EPS estimates in the past, indicating a strong operational performance.

The options market is pricing a smaller move than historical averages, suggesting that sentiment may be overly cautious.

Key Risk

If the EPS comes in below $2.40, it could undermine the positive sentiment surrounding the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Quest Diagnostics can sustain its growth and profitability in a competitive health care market.

Bull Confirmed If

An EPS of $2.60 or higher would confirm the bull case and suggest strong demand for diagnostic services.

Bear Confirmed If

An EPS below $2.40 would raise concerns about the company's growth prospects and confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±2.31%

Historical Avg

±5.7%

Pricing cheap

The options market is pricing in a modest move of about 2.31%, indicating that investors are anticipating a relatively stable reaction to the earnings report.

Options are pricing ±2.3% while DGX has averaged ±5.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

24.2%

Calls (31K)P/C Ratio: 0.25Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Quest Diagnostics beats expectations, history suggests the stock could rise by an average of 3.85%, confirming strong demand for its services.

In-Line / Cautious

If the results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.

Miss

If the company misses expectations, history suggests a potential decline of around 3.85%, indicating investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new diagnostic tests or services being launched.
2Management's commentary on trends in patient volume and demand for testing.
3Insights into cost management and operational efficiency improvements.
4Discussion on competitive pressures and market share dynamics.
5Guidance on future revenue growth and strategic initiatives.